Glaucoma in Seniors- Therapeutic Decisions


Authors : Evelina Marinova; Emilia Naseva; Dimitar Dabov

Volume/Issue : Volume 6 - 2021, Issue 6 - June

Google Scholar : http://bitly.ws/9nMw

Scribd : https://bit.ly/3wxJv27

Glaucoma is irreversible progressive optic neuropathy, for which the major proven treatment is to lower the intraocular pressure. Our study aims to present therapeutic decisions, used to treat glaucoma among the citizens of Sofia city aged 65 years and above. Data were collected in a prophylactic ophthalmic campaign, realized in the summer of 2016 and 2017, in Sofia city. All patients passed thorough ophthalmic examinations and filled penand-paper questionnaires. The predominant number of persons with glaucoma was treated with conservative monotherapy. Prostaglandin analogues have been prescribed to more than half of the patients. Fixed combinations have been used in 86% of the cases who needed combined therapy with two substances and in 100% of those with three medications. The therapeutic scheme used for treating glaucoma in seniors in Sofia city is similar and corresponding to practice worldwide. Conservative monotherapy is used in a mean of 45%. When combined therapy is necessary, fixed combinations are predominantly prescribed to minimize adverse events and to ensure better patients compliance. A tendency of usage of preservative-free formulas to benefit patients’ eye health has been noticed.

Keywords : Glaucoma, Seniors, Therapy, Fixed Combination, Medication.

CALL FOR PAPERS


Paper Submission Last Date
31 - October - 2021

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe